xeroma
Conditions
Interventions
Group 1:Sodium Hyaluronate eye drops and herb
Group 2:Sodium Hyaluronate eye drops
Sponsors
Beijing Tongren Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Patients who met the diagnostic criteria of evaporative type dry eye; 2. Meibomian gland dysfunction, MGD, group 1 to 3; 3. Syndrome differentiation of yin deficiency and yang hyperactivity in TCM; 4. Aged 18 to 60 years old; 5. Course more than 6 months.
Exclusion criteria
Exclusion criteria: 1. Meibomian gland dysfunction, MGD,group 4; 2. History of other eye diseases or ophthalmic surgery or laser treatment; 3. Other medical treatment has been used besides Sodium Hyaluronate Eye Dropsoutside in the past 2 weeks; 4. Sjogren's syndrome, rheumatism, rheumatoid, and other systemic immune diseases; 5. Combined with cardio cerebrovascular, lung, liver, kidney, hematopoietic system and other serious primary diseases; 6. Severe mental and neurological disorders; 7. Pregnancy, lactation, or preparation of pregnant women; 8. Allergic to Sodium Hyaluronate Eye Drops or allergic history of Chinese Medicine; 9. Refusing to sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ocular symptom score;Break-up time determination;Meibomian gland function determination;Thickness of lacrimal film liposome; | — |
Secondary
| Measure | Time frame |
|---|---|
| Schirmer;Determination of corneal lesions;Meibomian gland lipid examination;OSDI; | — |
Countries
China
Contacts
Public ContactHaihong Lian
Beijing Tongren Hospital, Capital Medical University
Outcome results
None listed